Kprx stock price.

Seelos Therapeutics Stock (NASDAQ: SEEL) stock price, news, charts, stock research, profile.

Kprx stock price. Things To Know About Kprx stock price.

Nov 27, 2023 · Stock Price Forecast. According to 3 stock analysts, the average 12-month stock price forecast for KPRX stock stock is $41.5, which predicts an increase of 7,117.39%. The lowest target is $2.00 and the highest is $119. On average, analysts rate KPRX stock stock as a strong buy. News Ideas Financials Technicals Forecast KPRX chart Today −0.69% 5 days −7.26% 1 month −4.17% 6 months −72.49% Year to date −83.43% 1 year −91.21% 5 years …The Price and 12 Month EPS chart displays the company's stock price along with the trailing twelve month (TTM) EPS. A company's earnings per share, or EPS, is a key financial metric on its income ...Stock analysis for Kiora Pharmaceuticals Inc (KPRX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and …

Brian Strem. https://www.kiorapharma.com. Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 1b clinical trial that acts as ...The 3 analysts offering 1 year price forecasts for KPRX have a max estimate of — and a min estimate of —. Analyst rating Based on 3 analysts giving stock ratings to KPRX in the past 3 months.Discover historical prices for XLE stock on Yahoo Finance. View daily, weekly or monthly format back to when Energy Select Sector SPDR Fund stock was issued.

View the latest Kroger Co. (KR) stock price, news, historical charts, analyst ratings and financial information from WSJ.Complete Kiora Pharmaceuticals Inc. stock information by Barron's. View real-time KPRX stock price and news, along with industry-best analysis.

0.20%. $7.78B. Acorda Therapeutics Inc. -1.31%. $11.98M. CPRX | Complete Catalyst Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial ... Search for ticker symbols for Stocks, Mutual Funds, ETFs, Indices and Futures on Yahoo! Finance.Mar 24, 2023 · 0. 0. According to 4 analyst offering 12-month price targets in the last 3 months, Kiora Pharmaceuticals has an average price target of $36.75 with a high of $119.00 and a low of $6.00. Below is a ... KPRX - Kiora Pharmaceuticals Inc Stock Price Quote - NASDAQ | Morningstar Kiora Pharmaceuticals Inc KPRX Morningstar Rating | Rating as of Oct 4, 2023 Quote Chart Stock Analysis News...Nov 6, 2023 · On November 6, 2023, Kiora Pharmaceuticals Inc (KPRX) experienced a significant increase in its stock performance. The company’s stock price had a median target of $2.00, with a high estimate of $33.00 and a low estimate of $2.00. This median estimate represents a remarkable 221.23% increase from the last recorded price of $0.62.

Kiora Pharmaceuticals Inc. stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... KPRX Stock Quotes ...

KPRX Stock 12 Months Forecast. $2.75. (347.15% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Kiora Pharmaceuticals in the last 3 months. The average price target is $2.75 with a high forecast of $3.50 and a low forecast of $2.00. The average price target represents a 347.15% change from the last price of $0.62.

FTSE 100 (UKX.L) LSE - LSE Delayed price. Currency in GBP. As of 03:35PM GMT. Market open. *Close price adjusted for splits. **Close price adjusted for splits and dividend and/or capital gain distributions. Get historical data for the FTSE 100 (UKX.L) on Yahoo Finance. View and download daily, weekly or monthly data to help with your investment ...Nov 10, 2023 · On Friday, Kiora Pharmaceuticals Inc (KPRX:NAQ) closed at 0.6335, 37.06% above the 52 week low of 0.4622 set on Sep 05, 2023. Data delayed at least 15 minutes, as of Nov 10 2023 20:59 GMT. Latest Kiora Pharmaceuticals Inc (KPRX:NAQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. Stock Prediction for the Price of One Kiora Pharmaceuticals Share in Oct 2025. In Oct 2025 analysts predict a share price of $0.71. An increase of 23.05% compared to today's share price.Get historical data for the NIFTY 50 (^NSEI) on Yahoo Finance. View and download daily, weekly or monthly data to help your investment decisions.Kiora Pharmaceuticals, Inc. Common Stock (KPRX) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.Kiora Pharmaceuticals (KPRX) stock dropped 50% on Friday after the firm priced an underwritten public offering for gross proceeds of ~$5.5M.The offering is comprised of ~1.4M shares,...

Mar 24, 2023 · 0. 0. According to 4 analyst offering 12-month price targets in the last 3 months, Kiora Pharmaceuticals has an average price target of $36.75 with a high of $119.00 and a low of $6.00. Below is a ... Nov 27, 2023 · According to the issued ratings of 3 analysts in the last year, the consensus rating for Kiora Pharmaceuticals stock is Buy based on the current 3 buy ratings for KPRX. The average twelve-month price prediction for Kiora Pharmaceuticals is $46.00 with a high price target of $119.00 and a low price target of $7.00. InvestorPlace is home to all of the hottest stock market news worth reading about today! Our coverage includes why shares of Kiora Pharmaceuticals (NASDAQ: KPRX) stock, Abercrombie & Fitch (NYSE ...5 analysts have issued 1-year price objectives for Aravive's shares. Their ARAV share price targets range from $9.00 to $18.00. On average, they anticipate the company's stock price to reach $12.25 in the next year. This suggests a possible upside of 8,907.4% from the stock's current price.Feb 10, 2023 ... ... price targets on the company's stock and three raising them. ... Kiora Pharmaceuticals (KPRX) shares zoomed 109% this week from $3.28 on Monday ...Nov 27, 2023 · According to the issued ratings of 3 analysts in the last year, the consensus rating for Kiora Pharmaceuticals stock is Buy based on the current 3 buy ratings for KPRX. The average twelve-month price prediction for Kiora Pharmaceuticals is $46.00 with a high price target of $119.00 and a low price target of $7.00.

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners.KPRX Stock 12 Months Forecast. $2.75. (347.15% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Kiora Pharmaceuticals in the last 3 months. The average price target is $2.75 with a high forecast of $3.50 and a low forecast of $2.00. The average price target represents a 347.15% change from the last price of $0.62.

Find the latest SoundHound AI, Inc. (SOUN) stock quote, history, news and other vital information to help you with your stock trading and investing.7:08a Clorox’s stock rises on J.P. Morgan upgrade to neutral from underweight 7:07a ‘Too many skunks at the party.’ Bank of America strategist charts S&P 500’s path to 5,000 Find the latest Unique Fabricating, Inc. (UFAB) stock quote, history, news and other vital information to help you with your stock trading and investing.What is KPRX stock price target? The target price for KPRX stock is $12.83 based on the average of what a group of analyst think KPRX stock could be worth at a future date. This is not a prediction by Public.com3 brokers have issued 1-year price targets for Kiora Pharmaceuticals' stock. Their KPRX share price targets range from $7.00 to $119.00. On average, they anticipate the company's stock price to reach $46.00 in the next year. This suggests a possible upside of 8,955.1% from the stock's current price. View analysts price targets for KPRX or view ...The problem with KPRX stock is that its shares have remained below the $1 minimum bid price for 30 consecutive business days. According to this filing, Kiora Pharmaceuticals now has 180 days to ...Get the latest Kiora Pharmaceuticals, Inc. (KPRX) stock news and headlines to help you in your trading and investing decisions.R$476.67B. Suncor Energy Inc. -0.47%. $57.67B. XOM | Complete Exxon Mobil Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Kiora Pharmaceuticals stock was originally listed at a price of $3,600.00 in Feb 13, 2015. If you had invested in Kiora Pharmaceuticals stock at $3,600.00, your return over the last …Track Kiora Pharmaceuticals Inc (KPRX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

Seelos Therapeutics Stock (NASDAQ: SEEL) stock price, news, charts, stock research, profile.

Kiora Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on developing and commercializing therapies for the treatment of ophthalmic diseases. Its pipeline consists of three product candidates, including KIO-101, KIO-301, and KIO-201. Its lead product, KIO-301, is a potential vision-restoring small molecule ...

Open a brokerage account and deposit funds in it to purchase stock in a company, explains the Wall Street Journal. Companies such as Charles Schwab, E-Trade, and Ameritrade provide brokerage services.The latest Kiora Pharmaceuticals stock prices, stock quotes, news, and KPRX history to help you invest and trade smarter.Kiora Pharmaceuticals, Inc. Common Stock (KPRX) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.According to the issued ratings of 4 analysts in the last year, the consensus rating for Catalyst Pharmaceuticals stock is Buy based on the current 4 buy ratings for CPRX. The average twelve-month price prediction for Catalyst Pharmaceuticals is $24.75 with a high price target of $27.00 and a low price target of $24.00.4 brokers have issued 12-month target prices for Galera Therapeutics' shares. Their GRTX share price targets range from $6.00 to $12.00. On average, they expect the company's share price to reach $7.75 in the next year. This suggests a possible upside of 5,503.8% from the stock's current price.Based on 4 Wall Street analysts offering 12 month price targets for Tempest Therapeutics in the last 3 months. The average price target is $21.67 with a high forecast of $47.00 and a low forecast of $8.00. The average price target represents a 452.81% change from the last price of $3.92. Highest Price Target $47.00. Average Price Target $21.67.Kiora Pharmaceuticals saw a increase in short interest in November. As of November 15th, there was short interest totaling 539,900 shares, an increase of 67.3% from the previous total of 322,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that ...Kiora Pharmaceuticals 's market cap is calculated by multiplying KPRX's current stock price of $0.53 by KPRX's total outstanding shares of 7,689,240. KPRX Stock 12 Months Forecast. $2.75. (347.15% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Kiora Pharmaceuticals in the last 3 months. The average price target is $2.75 with a high forecast of $3.50 and a low forecast of $2.00. The average price target represents a 347.15% change from the last price of $0.62.

Get the latest KPRX (KPRX) stock quote, charts, news and other financial information to help you make more informed trading and investment decisions. KPRX is a biopharmaceutical company that develops and commercializes products for neurological disorders.The latest price target for Palisade Bio ( NASDAQ: PALI) was reported by Ladenburg Thalmann on Tuesday, May 16, 2023. The analyst firm set a price target for 16.00 expecting PALI to rise to within ...The reverse stock split caused the price of KPRX stock to jump from its prior value of 18 cents per share when markets closed on Monday. This saw the stock opening on Tuesday at a price of $6.18 ...Instagram:https://instagram. etr bashigh leverage forex brokers usiso20022 tokenssolar energy stocks Sep 27, 2022 · The reverse stock split caused the price of KPRX stock to jump from its prior value of 18 cents per share when markets closed on Monday. This saw the stock opening on Tuesday at a price of $6.18. 0. 0. According to 4 analyst offering 12-month price targets in the last 3 months, Kiora Pharmaceuticals has an average price target of $36.75 with a high of $119.00 and a low of $6.00. Below is a ... draftkings stock markettesla rating The average twelve-month price prediction for Catalyst Pharmaceuticals is $24.75 with a high price target of $27.00 and a low price target of $24.00. Learn more on CPRX's analyst rating history. Do Wall Street analysts like Catalyst Pharmaceuticals more than its competitors? Analysts like Catalyst Pharmaceuticals more than other Medical companies. onetrip rental car protector Cassava Sciences stock price target raised to $145 from $111 at B. Riley. Aug. 3, 2021 at 7:58 a.m. ET by Tomi Kilgore.Kiora Pharmaceuticals Stock Chart and Share Price Forecast, Short-Term "KPRX" Stock Prediction for Next Days and Weeks Walletinvestor.com Kiora Pharmaceuticals Inc (KPRX) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024Find the latest GigaCloud Technology Inc. (GCT) stock quote, history, news and other vital information to help you with your stock trading and investing.